NF-κB regulates the stability and activity of p73 by inducing its proteolytic degradation through a ubiquitin-dependent proteasome pathway

Oncogene

Volumn 25, Issue 58, 2006, Pages 7608-7617

  Kikuchi, H ^a,b   Ozaki, T ^a   Furuya, K ^a   Hanamoto, T ^a,b   Nakanishi, M ^a   Yamamoto, H ^a   Yoshida, K ^a   Todo, S ^b   Nakagawara, A ^a  

^a CHIBA CANCER CENTER   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Apoptosis; NF B; p53; p73; Ubiquitination

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME; PROTEIN P50; PROTEIN P53; PROTEIN P73; PROTEIN P73ALPHA; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN; DNA BINDING PROTEIN; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DELETION MUTANT; HALF LIFE TIME; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; REGULATORY MECHANISM; UBIQUITINATION; ANIMAL; CELL STRAIN COS1; CERCOPITHECUS; CYTOLOGY; DOWN REGULATION; EMBRYO; FIBROBLAST; GENE DELETION; GENETICS; METABOLISM; PROTEIN PROCESSING; TUMOR CELL LINE;

MAMMALIA;

ANIMALS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; DNA-BINDING PROTEINS; DOWN-REGULATION; EMBRYO; FIBROBLASTS; GENE DELETION; HUMANS; MICE; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN;

EID: 33845527496     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209748     Document Type: Article

References (45)

1. Agami R, Blandino G, Oren M, Shaul Y. (1999). Nature 399: 809-813.
2. Balint E, Bates S, Vousden KH. (1999). Oncogene 18: 3923-3929.
3. Bayon Y, Ortiz MA, Lopez-hernandez FJ, Gao F, Karin M, Pfahl M et al. (2003). Mol Cell Biol 23: 1061-1074.
4. Beg AA, Baltimore D. (1996). Science 274: 782-784.
5. Beg AA, Sha WC, Bronson RT, Baltimore D. (1995). Nature 376: 167-170.
6. Bernassola F, Salomoni P, Oberst A, Di Como CJ, Pagano M, Melino G et al. (2004). J Exp Med 199: 1545-1557.
7. Bourdon JC, Fernandes K, Murray-Zmijewski F, Liu G, Diot A, Xirodimas DP et al. (2005). Genes Dev 19: 2122-2137.
8. Chang L, Kamata H, Solinas G, Luo JL, Maeda S, Venuprasad K et al. (2006). Cell 124: 601-613.
9. Flores ER, Tsai KY, Crowley D, Sengupta S, Yang A, McKeon F et al. (2002). Nature 416: 560-564.
10. Fontemaggi G, Gurtner A, Strano S, Higashi Y, Sacchi A, Piaggio G et al. (2001). Mol Cell Biol 21: 8461-8470.
11. Gong J, Costanzo A, Yang HQ, Melino G, Kaelin Jr WG, Levrero M et al. (1999). Nature 399: 806-809.
12. Gressner O, Schilling T, Lorenz K, Schulze Schleithoff E, Koch A, Schulze-Bergkamen H et al. (2005). EMBO J 24: 2458-2471.
13. Grob TJ, Novak U, Maisse C, Barcaroli D, Luthi AU, Pirnia F et al. (2001). Cell Death Differ 8: 1213-1223.
14. Huang TT, Wuerzberger-Davis SM, Seufzer BJ, Shumway SD, Kurama T, Boothman DA et al. (2000). J Biol Chem 275: 9501-9509.
15. Ikawa S, Nakagawara A, Ikawa Y. (1999). Cell Death Differ 6: 1154-1161.
16. Irwin MS, Kondo K, Marin MC, Cheng LS, Hahn WC, Kaelin Jr WG. (2003). Cancer Cell 3: 403-410.
17. Jost CA, Marin MC, Kaelin Jr WG. (1997). Nature 389: 191-194.
18. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A et al. (1997). Cell 90: 809-819.
19. Kawai H, Nie L, Yuan ZM. (2002). Mol Cell Biol 22: 6079-6088.
20. Kharbanda S, Ren R, Pandey P, Shafman TD, Feller SM, Weichselbaum RR et al. (1995). Nature 376: 785-788.
21. Kim JS, Lee JM, Chwae YJ, Kim YH, Lee JH, Kim K et al. (2004). Biochem Pharmacol 67: 1459-1468.
22. Kramer S, Ozaki T, Miyazaki K, Kato C, Hanamoto T, Nakagawara A. (2005). Oncogene 24: 938-944.
23. Lee CW, La Thangue NB. (1999). Oncogene 18: 4171-4181.
24. Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S et al. (2003). Cell 112: 779-791.
25. Lissy NA, Davis PK, Irwin M, Kaelin Jr WG, Dowdy SF. (2000). Nature 407: 642-645.
26. Mantovani F, Piazza S, Gostissa M, Strano S, Zacchi P, Mantovani R et al. (2004). Mol Cell 14: 625-636.
27. Melino G, De Laurenzi V, Vousden KH. (2002). Nat Rev Cancer 2: 605-615.
28. Muta T, Takeshige K. (2001). Eur J Biochem 268: 4580-4589.
29. Nakagawa T, Takahashi M, Ozaki T, Watanabe K, Todo S, Mizuguchi H et al. (2002). Mol Cell Biol 22: 2575-2585.
30. Pozniak CD, Radinovic S, Yang A, McKeon F, Kaplan DR, Miller FD. (2000). Science 289: 304-306.
31. Rossi M, De Laurenzi V, Munarriz E, Green DR, Liu YC, Vousden KH et al. (2005). EMBO J 24: 836-848.
32. Stiewe T, Putzer BM. (2002). Cell Death Differ 9: 237-245.
33. Stiewe T, Zimmermann S, Frilling A, Esche H, Putzer BM. (2002). Cancer Res 62: 3598-3602.
34. Strano S, Monti O, Pediconi N, Baccarini A, Fontemaggi G, Lapi E et al. (2005). Mol Cell 18: 447-459.
35. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. (1996). Science 274: 787-789.
36. Wan YY, DeGregori J. (2003). Immunity 18: 331-342.
37. Wang CY, Mayo MW, Baldwin ASJ. (1996). Science 274: 784-787.
38. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin SJ. (1998). Science 281: 1680-1683.
39. Yamagishi N, Miyakoshi J, Takebe H. (1997). Int J Radiat Biol 72: 157-162.
40. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V et al. (1998). Mol Cell 2: 305-316.
41. Yang A, McKeon F. (2000). Nat Rev Mol Cell Biol 1: 199-207.
42. Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J et al. (2000). Nature 404: 99-103.
43. Yuan ZM, Shioya H, Ishiko T, Sun X, Gu J, Huang YY et al. (1999). Nature 399: 814-817.
44. Zaika AI, Slade N, Erster SH, Sansome C, Joseph TW, Pearl M et al. (2002). J Exp Med 196: 765-780.
45. Zeng X, Chen L, Jost CA, Maya R, Keller D, Wang X et al. (1999). Mol Cell Biol 19: 3257-3266.